(marketscreener.com) Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC are investigating the proposed merger of Neoleukin Therapeutics, Inc. with Neurogene Inc. Under the terms of the proposed transaction, pre-merger Neoleukin stockholders are expected to own approximately 16% of the combined company and...https://www.marketscreener.com/quote/stock/NEOLEUKIN-THERAPEUTICS-I-65218886/news/NEOLEUKIN-THERAPEUTICS-INVESTOR-ALERT-by-the-Former-Attorney-General-of-Louisiana-Kahn-Swick-Foti-44413444/?utm_medium=RSS&utm_content=20230725
Neoleukin is a Washington-based biotechnology company that researches and develops novel therapeutics for the treatment of cancer and autoimmune diseases.